Eton New Logo.jpg
Eton Pharmaceuticals Announces FDA Approval of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) as Replacement Therapy in Pediatric Patients with Adrenocortical Insufficiency
29. September 2020 18:50 ET | Eton Pharmaceuticals
-ALKINDI SPRINKLE is the first and only FDA-approved granular hydrocortisone formulation for adrenocortical insufficiency specifically designed for children -Eton expects ALKINDI SPRINKLE to be...
Eton New Logo.jpg
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
16. September 2020 09:00 ET | Eton Pharmaceuticals
DEER PARK, Ill., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton New Logo.jpg
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
31. August 2020 08:00 ET | Eton Pharmaceuticals
DEER PARK, Ill., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton New Logo.jpg
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
12. August 2020 08:30 ET | Eton Pharmaceuticals
DEER PARK, Ill., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton New Logo.jpg
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
11. August 2020 09:00 ET | Eton Pharmaceuticals
DEER PARK, Ill., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton New Logo.jpg
Eton Pharmaceuticals to Report Second Quarter Financial Results on Wednesday, August 12, 2020
04. August 2020 16:10 ET | Eton Pharmaceuticals
DEER PARK, Ill., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton New Logo.jpg
Eton Pharmaceuticals Submits New Drug Application to the FDA for Zonisamide Oral Suspension (ET-104)
30. Juli 2020 08:00 ET | Eton Pharmaceuticals
- Application Submitted for the Treatment of Partial Seizures in Epilepsy Patients - Eton’s Patent-Pending Product Addresses Significant Unmet Need for a Liquid Formulation of Zonisamide -...
Eton New Logo.jpg
Eton Pharmaceuticals Submits New Drug Application to the FDA for Orphan Drug Dehydrated Alcohol Injection (DS-100)
27. Juli 2020 07:30 ET | Eton Pharmaceuticals
-Granted Orphan Drug Designation by the FDA for the Treatment of Methanol Poisoning -Since the Start of COVID-19, the FDA has Recalled More Than 75 Contaminated Hand Sanitizers Due to Risk of...
Eton New Logo.jpg
Eton Pharmaceuticals Announces First Quarter 2020 Financial Results
14. Mai 2020 16:02 ET | Eton Pharmaceuticals
DEER PARK, Ill., May 14, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton New Logo.jpg
Eton Pharmaceuticals Confirms First-to-File Patent Challenge on Elcys (Cysteine Hydrochloride Injection)
07. Mai 2020 08:00 ET | Eton Pharmaceuticals
-Eton confirms first-to-file ANDA referencing Exela Pharma Sciences’ Elcys product -Eton plans to file Post Grant Reviews in the U.S. Patent & Trademark Office challenging the validity of Exela’s...